These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7966101)

  • 1. Hyperthyroidism and radio-iodine therapy in a district general hospital.
    Child DF; Mughni MA; Hudson P; Williams CP; Harvey JN
    J R Soc Med; 1994 Oct; 87(10):578-80. PubMed ID: 7966101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy.
    Connell JM; Hilditch TE; McCruden DC; Robertson J; Alexander WD
    Eur J Nucl Med; 1984; 9(10):464-6. PubMed ID: 6510423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of treatment of hyperthyroidism.
    Bringmann IM; van Leeuwen BL; Hennemann G; Beckett GJ; Toft AD
    J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial.
    Bal CS; Kumar A; Chandra P
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6536-40. PubMed ID: 16189259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis.
    Tunbridge WM; Harsoulis P; Goolden AW
    Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases.
    Sugrue D; McEvoy M; Feely J; Drury MI
    Q J Med; 1980; 49(193):51-61. PubMed ID: 7433627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.
    Lewis A; Atkinson B; Bell P; Courtney H; McCance D; Mullan K; Hunter S
    Ulster Med J; 2013 May; 82(2):85-8. PubMed ID: 24082285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis?
    Toft AD; Irvine WJ; Seth J; Cameron EH
    Br Med J; 1978 Oct; 2(6145):1115-7. PubMed ID: 709256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch; Horst W
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotoxicosis--treatment by I131 therapy and early prediction of hypothyroidism following this therapy.
    Khanna CM; Jain SK; Walia RP
    J Assoc Physicians India; 1994 Jan; 42(1):36-8. PubMed ID: 7836246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
    Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
    Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed recovery of thyrotropin responsiveness after radioactive iodine therapy for hyperthyroidism.
    Albert SG; Goodgold HM; Chehade J; Kim J
    Am J Med Sci; 2000 Jun; 319(6):376-9. PubMed ID: 10875293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of free thyroxine and free triiodothyronine in thyrotoxicosis and hypothyroidism.
    Franklyn JA; Sheppard MC; Ramsden DB; Wilkinson R; Hoffenberg R
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):107-10. PubMed ID: 6420093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pursued objectives with the use of 131I for the treatment of hypothyroidism: analysis of 2 series receiving different doses].
    Aguayo J; Atria A; Pineda G
    Rev Med Chil; 1987 Apr; 115(4):308-13. PubMed ID: 3448739
    [No Abstract]   [Full Text] [Related]  

  • 17. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.
    Beckett GJ; Kellett HA; Gow SM; Hussey AJ; Hayes JD; Toft AD
    Br Med J (Clin Res Ed); 1985 Aug; 291(6493):427-31. PubMed ID: 3926229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile hyperthyroidism: an experience.
    Bhadada S; Bhansali A; Velayutham P; Masoodi SR
    Indian Pediatr; 2006 Apr; 43(4):301-7. PubMed ID: 16651668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism.
    Aro A; Huttunen JK; Lamberg BA; Pelkonen R; Ikkala E; Kuusisto A; Rissanen V; Salmi J; Tervonen S
    Acta Endocrinol (Copenh); 1981 Mar; 96(3):321-7. PubMed ID: 7211093
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term follow-up of treated hyperthyroid and hypothyroid patients.
    Leese GP; Jung RT; Scott A; Waugh N; Browning MC
    Health Bull (Edinb); 1993 May; 51(3):177-83. PubMed ID: 8325778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.